128 related articles for article (PubMed ID: 8209866)
1. Follicular dendritic cells have prognostic relevance in Hodgkin's disease.
Alavaikko MJ; Blanco G; Aine R; Lehtinen T; Fellbaum C; Taskinen PJ; Sarpola A; Hansmann ML
Am J Clin Pathol; 1994 Jun; 101(6):761-7. PubMed ID: 8209866
[TBL] [Abstract][Full Text] [Related]
2. Follicular dendritic cells in Hodgkin's disease.
Alavaikko MJ; Hansmann ML; Nebendahl C; Parwaresch MR; Lennert K
Am J Clin Pathol; 1991 Feb; 95(2):194-200. PubMed ID: 1992609
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of follicular dendritic cells in nodular sclerosing Hodgkin's disease.
Baur AS; Meugé-Moraw C; Michel G; Delacrétaz F
Histopathology; 1998 Jun; 32(6):512-20. PubMed ID: 9675590
[TBL] [Abstract][Full Text] [Related]
4. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
[TBL] [Abstract][Full Text] [Related]
5. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors.
von Wasielewski R; Seth S; Franklin J; Fischer R; Hübner K; Hansmann ML; Diehl V; Georgii A
Blood; 2000 Feb; 95(4):1207-13. PubMed ID: 10666192
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Hodgkin's disease at diagnosis in young children.
White L; McCourt BA; Isaacs H; Siegel SE; Stowe SM; Higgins GR
Am J Pediatr Hematol Oncol; 1983; 5(3):251-7. PubMed ID: 6625107
[TBL] [Abstract][Full Text] [Related]
7. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type.
Hansmann ML; Stein H; Dallenbach F; Fellbaum C
Am J Pathol; 1991 Jan; 138(1):29-36. PubMed ID: 1987769
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy.
Björkholm M; Holm G; Mellstedt H; Johansson B; Askergren J; Söderberg G
Scand J Haematol; 1977 Nov; 19(5):487-95. PubMed ID: 594663
[TBL] [Abstract][Full Text] [Related]
9. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
10. Progressive transformation of germinal centers with and without association to Hodgkin's disease.
Hansmann ML; Fellbaum C; Hui PK; Moubayed P
Am J Clin Pathol; 1990 Feb; 93(2):219-26. PubMed ID: 2405631
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular).
Hansmann ML; Zwingers T; Böske A; Löffler H; Lennert K
J Cancer Res Clin Oncol; 1984; 108(3):321-30. PubMed ID: 6511805
[TBL] [Abstract][Full Text] [Related]
12. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
Asano N; Oshiro A; Matsuo K; Kagami Y; Ishida F; Suzuki R; Kinoshita T; Shimoyama Y; Tamaru J; Yoshino T; Kitamura K; Fukutani H; Morishima Y; Nakamura S
J Clin Oncol; 2006 Oct; 24(28):4626-33. PubMed ID: 16954517
[TBL] [Abstract][Full Text] [Related]
14. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's disease: a clinicopathologic study of 659 cases.
Colby TV; Hoppe RT; Warnke RA
Cancer; 1982 May; 49(9):1848-58. PubMed ID: 7074584
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
[TBL] [Abstract][Full Text] [Related]
17. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease.
Regula DP; Hoppe RT; Weiss LM
N Engl J Med; 1988 Jan; 318(4):214-9. PubMed ID: 3336412
[TBL] [Abstract][Full Text] [Related]
18. Histological Studies in Hodgkin's disease.
Elsner B
Beitr Pathol; 1975 Nov; 156(2):101-8. PubMed ID: 1212162
[TBL] [Abstract][Full Text] [Related]
19. Feline Hodgkin's-like lymphoma: 20 cases (1992-1999).
Walton RM; Hendrick MJ
Vet Pathol; 2001 Sep; 38(5):504-11. PubMed ID: 11572557
[TBL] [Abstract][Full Text] [Related]
20. Nucleoli and AgNORs in Hodgkin's disease.
Mamaev NN; Medvedeva NV; Shust VF; Markochev AB; Pasternak ND
Mol Pathol; 1997 Jun; 50(3):149-52. PubMed ID: 9292150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
